CD34 Cancer Research Results

CD34, CD34 transmembrane phosphoglycoprotein protein: Click to Expand ⟱

Source:

Type:

CD34 is a transmembrane phosphoglycoprotein protein that is expressed on the surface of certain cells, including hematopoietic stem cells, endothelial progenitor cells, and some cancer cells. In the context of cancer, CD34 has been studied as a potential biomarker and therapeutic target.
CD34 has been shown to be expressed on cancer stem cells in various types of cancer, including leukemia, breast cancer, and lung cancer.

Ovarian, Ovarian Cancer: Click to Expand ⟱

Ovarian Cancer

Scientific Papers found: Click to Expand⟱

4660-

Ash,

Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells

in-vitro,

Ovarian,

CSCs↓, TumCG↓, TumMeta↓, CD44↓, CD34↓, OCT4↓, NOTCH1↓, HEY1↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Cell Death ⓘ

HEY1↓, 1,

Proliferation, Differentiation & Cell State ⓘ

CD34↓, 1, CD44↓, 1, CSCs↓, 1, NOTCH1↓, 1, OCT4↓, 1, TumCG↓, 1,

Migration ⓘ

TumMeta↓, 1,
Total Targets: 8

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: CD34, CD34 transmembrane phosphoglycoprotein protein

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells